Department of Surgery, Arnau de Vilanova University Hospital, SanClemente 12, 46015, Valencia, Spain.
Research Department, Arnau de Vilanova University Hospital, Valencia, Spain.
World J Surg. 2021 Sep;45(9):2734-2741. doi: 10.1007/s00268-021-06164-7. Epub 2021 May 20.
Long-term extension of a previous randomized controlled clinical trial comparing open (OVHR) vs. laparoscopic (LVHR) ventral hernia repair, assessing recurrence, reoperation, mesh-related complications and self-reported quality of life with 10 years of follow-up.
Eighty-five patients were followed up to assess recurrence (main endpoint), reoperation, mesh complications and death, from the date of index until recurrence, death or study completion, whichever was first. Recurrence, reoperation rates and death were estimated by intention to treat. Mesh-related complications were only assessed in the LVHR group, excluding conversions (intraperitoneal onlay; n = 40). Quality of life, using the European Hernia Society Quality of Life score, was assessed in surviving non-reoperated patients (n = 47).
The incidence rates with 10 person-years of follow-up were 21.01% (CI 13.24-33.36) for recurrence, 11.92% (CI: 6.60-21.53) for reoperation and 24.88% (CI 16.81-36.82) for death. Sixty-two percent of recurrences occurred within the first 2 years of follow-up. No significant differences between arms were found in any of the outcomes analyzed. Incidence rate of intraperitoneal mesh complications with 10 person-years of follow-up was 6.15% (CI 1.99-19.09). The mean EuraHS-QoL score with 13.8 years of mean follow-up for living non-reoperated patients was 6.63 (CI 4.50-8.78) over 90 possible points with no significant differences between arms.
In incisional ventral hernias with wall defects up to 15 cm wide, laparoscopic repair seems to be as safe and effective as open techniques, with no long-term differences in recurrence and reoperation rates or global quality of life, although lack of statistical power does not allow definitive conclusions on equivalence between alternatives.
ClinicalTrial.gov (NCT04192838).
对先前一项比较开放式(OVHR)与腹腔镜式(LVHR)腹壁疝修补术的随机对照临床试验进行长期扩展,评估 10 年随访时的复发、再次手术、补片相关并发症和自我报告的生活质量。
85 例患者接受随访,以评估复发(主要终点)、再次手术、补片并发症和死亡,从指数日期到复发、死亡或研究完成(以先发生者为准)。通过意向治疗估计复发、再次手术率和死亡率。仅在 LVHR 组评估补片相关并发症,不包括转换病例(腹腔内上置补片;n=40)。在幸存未再次手术的患者(n=47)中,使用欧洲疝学会生活质量评分评估生活质量。
10 人年随访的发生率为:复发 21.01%(95%CI 13.24-33.36)、再次手术 11.92%(95%CI:6.60-21.53)和死亡 24.88%(95%CI 16.81-36.82)。62%的复发发生在随访的前 2 年内。在分析的任何结果中,两组之间均未发现显著差异。10 人年随访的腹腔内补片并发症发生率为 6.15%(95%CI 1.99-19.09)。13.8 年平均随访时,生活质量未再次手术的患者平均 EuraHS-QoL 评分为 6.63(95%CI 4.50-8.78),满分为 90 分,两组之间无显著差异。
在腹壁缺损宽度达 15cm 的切口疝中,腹腔镜修补术与开放式技术一样安全有效,在复发和再次手术率或整体生活质量方面没有长期差异,尽管缺乏统计学效力,无法对替代方案的等效性做出明确结论。
ClinicalTrials.gov(NCT04192838)。